Bhoiwala Devang L, Koleilat Issam, Qian Jiang, Beyer Barbara, Hushmendy Shazaan F, Mathew Alex, Bhoiwala Dipti L, Ferland Russell J, Crawford Dana R
Center for Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208, USA.
Neurol Res. 2013 Jan;35(1):79-89. doi: 10.1179/1743132812Y.0000000117.
Recent evidence supports the involvement of RCAN1 in Down syndrome and Alzheimer's disease. To better assess this, we generated and analyzed transgenic mice overexpressing human RCAN1 isoform 4 in neurons.
Cognitive behavioral (Morris water maze, open field, zero maze, elevated plus maze assays); cognitive-associated proteins (CREB, ERK and Tau Western immunoblotting); motor coordination (Rotarod assay); structural abnormalities (immunohistological analyses), and proinflammatory cytokines (cytometric bead assay) were measured in young (2 month) and old (18 month) transgenics and compared with wild type controls.
In old mice, male but not female transgenics exhibited a significant decrease in anxiety as compared with wild type controls, whereas female but not male transgenic mice exhibited significantly less motor coordination. No differences were observed in the Morris water maze (spatial learning). pERK levels were reduced in transgenic males but not females, while no differences were observed between genotypes for pCREB and pTau. In young mice, a modest learning and exploratory behavior was observed in transgenic mice using a limited number of mice, and at higher N values, pCREB and pERK (but not pTau) levels were reduced in transgenics. No macro- and micro-scopic structural abnormalities or proinflammatory cytokine level differences were observed.
These results indicate that elevated RCAN1 isoform 4 in neurons leads to a modest cognition-related impairment that is overall stronger at 2 months, suggesting a compensatory adaptation over time. These RCAN1 isoform 4 effects may contribute to at least some of the observed phenotypes in individuals with Down syndrome and Alzheimer's.
最近的证据支持RCAN1与唐氏综合征和阿尔茨海默病有关。为了更好地评估这一点,我们构建并分析了在神经元中过表达人RCAN1亚型4的转基因小鼠。
对年轻(2个月)和年老(18个月)的转基因小鼠进行认知行为测试(莫里斯水迷宫、旷场实验、零迷宫、高架十字迷宫实验);检测认知相关蛋白(CREB、ERK和Tau的蛋白质免疫印迹法);运动协调性测试(转棒实验);结构异常检测(免疫组织学分析)以及促炎细胞因子检测(细胞计数珠分析法),并与野生型对照进行比较。
在老年小鼠中,雄性而非雌性转基因小鼠与野生型对照相比焦虑显著降低,而雌性而非雄性转基因小鼠运动协调性显著降低。在莫里斯水迷宫实验(空间学习)中未观察到差异。转基因雄性小鼠中pERK水平降低,而雌性小鼠中未降低,pCREB和pTau在不同基因型之间未观察到差异。在年轻小鼠中,使用数量有限的小鼠观察到转基因小鼠有适度的学习和探索行为,在更高样本量时,转基因小鼠中pCREB和pERK(而非pTau)水平降低。未观察到宏观和微观结构异常或促炎细胞因子水平差异。
这些结果表明,神经元中RCAN1亚型4水平升高会导致适度的认知相关损伤,总体上在2个月时更强,提示随时间有代偿性适应。这些RCAN1亚型4的作用可能至少部分导致了唐氏综合征和阿尔茨海默病患者中观察到的一些表型。